HIGHLIGHTS
- What: The authors have evaluated the prognostic value of achieving a complete hematological response (CHR) and developing resistance/intolerance to HU in a contemporary series of 1080 patients included in the Spanish Registry of Essential Thrombocythemia.
- Who: Posted Date August et al. from the Institut Català d`Oncologia Girona, Josep Trueta have published the Article: Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia, in the Journal: (JOURNAL)
- How: When ET diagnosis was previous to the inclusion in the registry clinical data were collected retrospectively and prospectively . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.